Viking Therapeutics, Inc. (VKTX)
34.15
+0.92
(+2.77%)
USD |
NASDAQ |
Aug 25, 14:44
Viking Therapeutics Total Assets (Quarterly) : 521.90M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 521.90M |
| March 31, 2026 | 608.24M |
| December 31, 2025 | 715.73M |
| September 30, 2025 | 739.42M |
| June 30, 2025 | 827.85M |
| March 31, 2025 | 866.99M |
| December 31, 2024 | 908.32M |
| September 30, 2024 | 937.89M |
| June 30, 2024 | 946.84M |
| March 31, 2024 | 967.52M |
| December 31, 2023 | 368.49M |
| September 30, 2023 | 382.66M |
| June 30, 2023 | 400.69M |
| March 31, 2023 | 150.90M |
| December 31, 2022 | 168.53M |
| September 30, 2022 | 166.68M |
| June 30, 2022 | 181.51M |
| March 31, 2022 | 195.03M |
| December 31, 2021 | 210.66M |
| September 30, 2021 | 224.47M |
| June 30, 2021 | 237.84M |
| March 31, 2021 | 250.14M |
| December 31, 2020 | 256.50M |
| September 30, 2020 | 263.62M |
| June 30, 2020 | 271.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 277.10M |
| December 31, 2019 | 284.26M |
| September 30, 2019 | 290.12M |
| June 30, 2019 | 294.49M |
| March 31, 2019 | 300.08M |
| December 31, 2018 | 302.31M |
| September 30, 2018 | 306.80M |
| June 30, 2018 | 144.47M |
| March 31, 2018 | 78.97M |
| December 31, 2017 | 22.12M |
| September 30, 2017 | 11.84M |
| June 30, 2017 | 14.32M |
| March 31, 2017 | 15.15M |
| December 31, 2016 | 14.54M |
| September 30, 2016 | 16.32M |
| June 30, 2016 | 18.55M |
| March 31, 2016 | 12.76M |
| December 31, 2015 | 15.44M |
| September 30, 2015 | 19.01M |
| June 30, 2015 | 22.27M |
| March 31, 2015 | 2.769M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 2.014M |
| March 31, 2014 | 0.0896M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 27.42B |
| Eli Lilly & Co. | 142.28B |
| Regeneron Pharmaceuticals, Inc. | 41.73B |
| Skye Bioscience, Inc. | 11.03M |
| Eledon Pharmaceuticals, Inc. | 126.09M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 113.58M |
| Shareholders Equity (Quarterly) | 408.32M |
| Debt to Equity Ratio | 0.01 |
| Current Ratio | 4.720 |
| Net Debt Paydown Yield | -0.01% |